1 / 21

MRCPsych addiction psychiatry seminar series

MRCPsych addiction psychiatry seminar series. Policy, guidance, service structures and legal framework of addiction treatment Epidemiology of addictive disorder Psychological interventions Management of tobacco use and addiction Dr Stuart McLaren March 2010.

noma
Download Presentation

MRCPsych addiction psychiatry seminar series

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. MRCPsych addiction psychiatry seminar series • Policy, guidance, service structures and legal framework of addiction treatment • Epidemiology of addictive disorder • Psychological interventions • Management of tobacco use and addiction Dr Stuart McLaren March 2010

  2. Policy, guidance, service structures and legal framework

  3. UK drug policy • 1998 Tackling drugs to build a better Britain – 10 year strategy • 2002, updated 2006 Models of Care for drug misusers • 2006 Models of Care for alcohol misusers • 2008 Drugs: protecting families and communities – next 10 year strategy

  4. UK Drug Strategy • NTORS/effectiveness review/NICE • NTA/Healthcare commission • NDTMS • TOP • Harm reduction approach • Criminal justice initiatives

  5. Harm reduction approach Defines policies, programmes, services and activities (treatments) that work to reduce the: • Health, social and economic harms to: • Individuals, communities, and society that are associated with drug use.

  6. Factors associated with harm • Route of injection • Nature, extent and pattern of use • Prevalence of BBVs in IDUs population • Life style factors associated with use • Drug policy environment • Characteristics of healthcare environment

  7. Specific health problems • Drug overdose • HIV, hepatitis B & C • Bacterial infections, including TB • Fungal infections • Venous and arterial problems • Dental problems • Respiratory and cardiovascular promblems • Mental illness • Violence

  8. Harm reductions approaches to injecting drug use • Needle (-syringe) exchange programmes • Substitute prescribing treatment • HIV/AIDS related treatment • Hepatitis B vaccination • Hepatitis C testing • Information, advice and education

  9. NICE guidance 2007 • Technology appraisals: -Methadone and buprenorphine for the management of opioid dependence (TAG 114) -Naltrexone for the management of opioid dependence (TAG 115)

  10. NICE guidance 2007 • Clinical guidelines -Drug misuse: opioid detoxification -Drug misuse: psychosocial interventions

  11. Department of Health guidelines 2007 Drug misuse and dependence: UK guidelines on clinical management ‘the orange book’

  12. UK commissioning structure National Treatment Agency Drug (A) Action Teams Providers

  13. Structure of treatment services • Residential rehabilitation houses • Inpatient units • Regional drug services • Specialist, statutory drug services • Shared care/primary care services • Non-statutory, street-level services • Self -help groups

  14. Structure of treatment services • Tier 4 residential • Tier 3 structured community based • Tier 2 open access (usually non-statutory) • Tier 1 interface services

  15. Home Office drug initiatives • Police custody – drug testing, arrest referral schemes • Courts and probation – drug monitoring, RoB, DRRs • Prison – CARAT teams • Aftercare

  16. Misuse of Drugs Act 1971 and Regulations 2001 • Class A – cocaine, ecstasy, heroin, LSD, methadone, Class B drugs injected • Class B – amphetamines, barbiturates, codeine • Class C – anabolic steroids, minor tranquillisers, cannabis

  17. Misuse of Drugs Act – maximum penalties possessiontrafficking Class A7 years + fine life + fine Class B 5 years + fine 14 years + fine Class C 2 years + fine 5 years + fine

  18. Regulations • Schedule 1 – no therapeutic value (cannabis,LSD) • Schedule 2 & 3 – can be prescribed (heroin, amphetamine, temazepam) • Schedule 4 – can be prescribed (mostly benzodiazepines) • Schedule 5 – over the counter medications

  19. Implications Doctors can prescribe: Amphetamines Barbiturates Cocaine** Heroin** Methadone ** need HO license to prescribe to ‘addicts’

  20. Mental Health Act 1983 Part I application of Act ‘Nothing… above shall be construed as implying that a person may be dealt with under this Act as suffering from mental disorder….by reason of…dependence on alcohol or drugs’

  21. Mental & behavioural disorders due to psychoactive substance use • F1x.4 withdrawal state with delirium • F1x.5 psychotic disorder • F1x.6 amnesic disorder • F1x.7 residual and late-onset psychotic disorder

More Related